SCHEMBL24487155

SCHEMBL24487155

CCN(CC)CCNC(=S)N(C)c1cc(=O)oc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.43
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ BRD4 O60885 5/20 0.41
▸ DRD4 P21917 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.39
▸ XDH P47989 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ TP53 P04637 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ EGFR P00533 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24486749 0.89 RECQL (0.41) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24820184 0.88 BRD4 (0.43) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24486930 0.82 RECQL (0.43) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24818349 0.81 RECQL (0.42) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24820185 0.81 RECQL (0.41) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24820252 0.80 RECQL (0.40) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24487223 0.80 RECQL (0.41) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24486805 0.78 CYP1A2 (0.41) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL24486803 0.78 RECQL (0.40) RECQLCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL21533749 0.76 MEN1 (0.42) RECQLCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220412963-A1 FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION 2022-12-29 — — US disclosed
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, ST3GAL3 RECQL 2746/4885CYP1A2 3513/4885CYP3A4 1358/4885
US-20220412963-A1 FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS FUT5, FUT6, OGT RECQL 4851/4885CYP1A2 2545/4885CYP3A4 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback